SINT (SINTX Technologies) Risk Assessment


SINT SINTX Technologies Inc SINT
23 GF Score
Price $1.90
GF Value $0.15
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is SINTX Technologies Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of SINTX Technologies is: High Risk: High uncertainty with risk-return tradeoff.

SINTX Technologies  (NAS:SINT) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

SINTX Technologies Risk Assessment Related Terms

SINT vs ALRTF, CODX, PMI: Risk Assessment Comparison

For the Medical Devices subindustry, SINTX Technologies's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SINTX Technologies Risk Assessment vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SINTX Technologies's Risk Assessment distribution charts can be found below:

* The bar in red indicates where SINTX Technologies's Risk Assessment falls into.


SINT
23GF Score
SINTX Technologies Inc SINT
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is SINTX Technologies (SINT) Overvalued in 2026?

Based on GuruFocus' analysis, SINTX Technologies stock appears to be overvalued. The current stock price of $1.90 is trading 1166.7% above its estimated GF Value™ of $0.15. GuruFocus considers SINTX Technologies to be Significantly Overvalued.

Key valuation signals for SINT:

  • Risk Assessment:
  • GF Value™: $0.15 vs. price of $1.90 (1166.7% above fair value)
  • GF Score™: 23/100 with 7 warning signs

No single metric tells the full story. See the SINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SINTX Technologies Business Description

Other Exchanges 0A8S:UK
Address 1885 West 2100 South, Salt Lake City, UT, USA, 84119
SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.
23GF Score

Get the complete analysis for SINT

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.90
Price
$0.15
GF Value